US equities |
MU $987.28 ▼-4.05% META $743.49 ▲+3.45% NVDA $226.72 ▼-1.12% SNDK $1,485.66 ▼-6.08% SPCX $163.79 ▲+0.75% AMD $593.17 ▼-2.46% MSFT $539.83 ▲+0.89% TSLA $377.94 ▼-1.24%
FinancialContent

Articles published by CervoMed Inc.

News headline image
CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
From CervoMed Inc.
Via GlobeNewswire
Tickers CRVO